Merck to Complete Acquisition of Cidara Therapeutics
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| Fidelity Advisor Small Cap independence Fund Class T (NASDAQ: CDTX) | Delayed: 221.38 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $221.38 | 52 Week High | $18.07 | |||
| Open | $221.38 | 52 Week Low | $8.65 | |||
| Day High | $221.38 | P/E | N/A | |||
| Day Low | $221.38 | EPS | $0.00 | |||
| Volume | 2,394 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 142.08 +1.47 (1.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $140.61 | 52 Week High | $65.46 | |||
| Open | $140.22 | 52 Week Low | $47.97 | |||
| Day High | $142.69 | P/E | 96.65 | |||
| Day Low | $139.83 | EPS | $1.47 | |||
| Volume | 3,686,980 | |||||
